Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Precipio™ HemeScreen BCR/ABL1 Panel-20

The HemeScreen BCR/ABL1 Panel-20 is an RUO reagent set kit used to screen for 3 major BCR/ABL1 isoforms (p190, p210, and p230) and 1 minor isoform (p203) associated with BCR/ABL1-induced leukemogenesis, including CML and ALL using HRM methods.

Supplier:  Precipio™ HS20RBCR

Catalog No. 22-021-973


Explore available promotions
Add to Cart
This item is not returnable. View return policy

Description

Description

HemeScreen is a proprietary set of RUO (Research Use Only) reagents used to screen the wild type (Negative) from Mutated (Positive) genes in a simplified workflow relative to alternative molecular testing technologies (RT-PCR or NGS).

  • Isoforms tested: p190, p203, p210, p230
  • Simplified workflow and reduced chance of error
  • Data capture during thermocycling
  • Fast turnaround time
  • Broad mutation detection (SNPs, Modifications, Indels)
  • Low limits of detection
  • Results are qualitative and DNA sequencing is required to identify specific isoforms
  • LOD: 5%
  • Assay includes Primers-Mastermix Mix and positive controls
  • Requires HRM-enabled RT-PCR (example Thermo Fisher™ Quantstudio 3 or higher)
Specifications

Specifications

3 x 5 mL Tube Primer Sets, 4 x 1.5 mL Tube Mutant Controls. Store at -20°C
PCR Instruments
20 Samples
Dry Ice
HRM
Yes
0.95
>99%
Safety and Handling

Safety and Handling

ShelfLife : 1 Year

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.